Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers
- PMID: 17564591
- DOI: 10.1111/j.1365-3016.2007.00811.x
Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers
Abstract
Implementation of national guidelines for the prevention of group B streptococcal (GBS) infections has led to an increase in intrapartum antibiotic use and reduction in early-onset GBS infections in newborns. Other outcomes, including the clinical diagnosis of sepsis in term infants, treatment with antibiotics, length of stay, and cost have not been described. To examine these outcomes, we performed an analysis of maternal and newborn data collected between 1998 and 2002 of 130 447 in-hospital births of newborns >or=37 weeks gestation and their mothers from a large vertically integrated healthcare organisation in Utah. The main outcome measures included: (i) the number of women delivering at term who received intravenous antibiotics; (ii) the number of newborns treated for 'clinical sepsis', which was defined as receiving antibiotics for >72 h and the number of newborns who received antibiotics for <or=48 h, i.e. a 'rule-out-sepsis' course. We also compared the lengths of stay and variable costs of infants whose mothers received antibiotics with those whose mothers did not. We found that the proportion of mothers who received intravenous antibiotics rose from 26.8% in 1998 to 40.6% in 2002 (P < 0.0001). The proportion of newborns treated for clinical sepsis ranged from 1.2% to 1.4% over the 5-year period. (P for trend = 0.04). After controlling for maternal chorioamnionitis, delivery by caesarean section and maternal GBS status, newborns of mothers who received antibiotics were significantly more likely to be treated for clinical sepsis than were newborns of mothers who had not received them [adjusted OR = 3.3; 95% CI 2.9, 3.8]. The average length of stay for newborns whose mothers were treated with antibiotics was 55.8 h compared with 41.6 h for those not treated (P < 0.0001). The cost of caring for newborns whose mothers received antibiotics was $740 compared with $638 for those whose mothers had not received them (P < 0.001).
Similar articles
-
Early-onset group B streptococcal disease in the era of maternal screening.Pediatrics. 2005 May;115(5):1240-6. doi: 10.1542/peds.2004-2275. Pediatrics. 2005. PMID: 15867030
-
Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns.Pediatrics. 1994 Apr;93(4):631-5. Pediatrics. 1994. PMID: 8134220 Clinical Trial.
-
Pilot study to prevent early-onset Group B Streptococcal disease in newborns.Adv Neonatal Care. 2006 Aug;6(4):208-19. doi: 10.1016/j.adnc.2006.04.006. Adv Neonatal Care. 2006. PMID: 16890133
-
Prevention of group B streptococcal disease in the newborn.Am Fam Physician. 2005 Mar 1;71(5):903-10. Am Fam Physician. 2005. PMID: 15768620 Review.
-
Prevention of neonatal group B streptococcal infection.Am Fam Physician. 1998 Jun;57(11):2713-20, 2725. Am Fam Physician. 1998. PMID: 9636335 Review.
Cited by
-
Postnatal pediatric systemic antibiotic episodes during the first three years of life are not associated with mode of delivery.PLoS One. 2020 Mar 4;15(3):e0229861. doi: 10.1371/journal.pone.0229861. eCollection 2020. PLoS One. 2020. PMID: 32130278 Free PMC article.
-
Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies.Ital J Pediatr. 2017 Nov 2;43(1):98. doi: 10.1186/s13052-017-0409-1. Ital J Pediatr. 2017. PMID: 29096709 Free PMC article.
-
Empirical use of antibiotic therapy in the prevention of early onset sepsis in neonates: a pilot study.Arch Med Sci. 2016 Jun 1;12(3):603-13. doi: 10.5114/aoms.2015.51208. Epub 2015 Apr 28. Arch Med Sci. 2016. PMID: 27279855 Free PMC article.
-
Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.Pediatrics. 2013 Jul;132(1):e17-24. doi: 10.1542/peds.2012-3900. Epub 2013 Jun 3. Pediatrics. 2013. PMID: 23733800 Free PMC article.
-
Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.Infect Dis Obstet Gynecol. 2009;2009:934698. doi: 10.1155/2009/934698. Epub 2009 Dec 13. Infect Dis Obstet Gynecol. 2009. PMID: 20052397 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
